In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability.
Supporting Information
In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability Table S1 . Specific mass transitions of the identified metabolites included in the MRM method used for the analysis of the metabolite spectrum of 3,5-AB-CHMFUPPYCA. -CHMFUPPYCA 1  65  6  25  13  401  260  10  3,5-AB-CHMFUPPYCA 2  65  6  33  14  401  189  10  3,5-AB-CHMFUPPYCA 3  65  6  52  24  402  356  10  primary amid hydrolysis 1  65  6  25  13  402  260  10  primary amid hydrolysis 2  65  6  33  14  402  189 Supplemental Figure S1 . Enhanced product ion scans of 3,5-AB-CHMFUPPYCA (top) and 5,3-AB-CHMFUPPYCA (bottom) recorded using a collision energy of 35 V with a spread of 15 V and proposed fragmentation. The main fragment ions m/z 260 and m/z 285 are suitable for a differentiation of the two isomers. Figure S2 . Comparison of the metabolic profiles of 3,5-AB-CHMFUPPYCA (top) and 5,3-AB-CHMFUPPYCA (bottom) after recording a multiple reaction monitoring scan using the most abundant ion transitions for each identified metabolite (see Supplemental Table S1 and S2 for a list of the metabolites and the respective ion transitions). pHLM assays were performed with the same starting concentration for both substrates. Supplemental Figure S3 . Investigation of the thermal stability of 3,5-AB-CHMFUPPYCA (left) and 5,3-AB-CHMFUPPYCA (right). For the 3,5-isomer the metabolites A20, A21 and A22 were also formed artificially by amide cleavage and dehydrogenation under smoking conditions. For 5,3-AB-CHMFUPPYCA, the metabolites B20, B21, B22 and B23 were identified in the smoke condensate. The area ratios (degradation product/parent compound) are shown in comparison of the pHLM sample for each isomer. 
